12:00 AM
 | 
Jul 02, 2007
 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes

Company Bank Analyst Coverage Opinion Wk chg 6/29 cls
ArQule (ARQL) Fortis David Garrett Price target Buy 1% $7.05
Garrett lowered his target to $14 from $16, citing a recent biotech sector selloff rather than changes in the cancer company's fundamentals.
Aspreva (TSX:ASV; ASPV) Pacific Growth Liana Moussatos

Read the full 343 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >